US20180147202A1
(en)
|
2015-06-05 |
2018-05-31 |
Arvinas, Inc. |
TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF PROTEINS CONTAINING BROMODOMAIN
|
CN109562107A
(zh)
|
2016-05-10 |
2019-04-02 |
C4医药公司 |
用于靶蛋白降解的杂环降解决定子体
|
CN109641874A
(zh)
|
2016-05-10 |
2019-04-16 |
C4医药公司 |
用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
|
WO2017197036A1
(en)
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
WO2018053354A1
(en)
|
2016-09-15 |
2018-03-22 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
IL290809B2
(en)
|
2016-11-01 |
2024-01-01 |
Arvinas Operations Inc |
PROTACS Targeted Tau-Protein and Related Methods of Use
|
CN110291087A
(zh)
|
2016-12-01 |
2019-09-27 |
阿尔维纳斯运营股份有限公司 |
作为雌激素受体降解剂的四氢萘和四氢异喹啉衍生物
|
US11173211B2
(en)
|
2016-12-23 |
2021-11-16 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides
|
BR112019012682A2
(pt)
|
2016-12-23 |
2019-12-17 |
Arvinas Operations Inc |
moléculas quiméricas visando a proteólise de egfr e métodos associados de uso
|
EP3559006A4
(en)
|
2016-12-23 |
2021-03-03 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF FETAL LIVER KINASE POLYPEPTIDES
|
WO2018119448A1
(en)
|
2016-12-23 |
2018-06-28 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptides
|
US11191741B2
(en)
|
2016-12-24 |
2021-12-07 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
|
JP7266526B6
(ja)
|
2017-01-26 |
2024-02-15 |
アルビナス・オペレーションズ・インコーポレイテッド |
エストロゲン受容体タンパク質分解性の調節因子およびその関連方法
|
KR102014478B1
(ko)
*
|
2017-05-12 |
2019-08-26 |
한국화학연구원 |
신규한 피페리딘-2,6-디온 유도체 및 이의 용도
|
WO2018237026A1
(en)
|
2017-06-20 |
2018-12-27 |
C4 Therapeutics, Inc. |
N / O-LINKED DEGRONS AND DEGRONIMERS FOR DEGRADATION OF PROTEINS
|
KR102656934B1
(ko)
|
2017-07-10 |
2024-04-16 |
셀진 코포레이션 |
항증식성 화합물 및 이의 사용 방법
|
WO2019043208A1
(en)
|
2017-09-04 |
2019-03-07 |
F. Hoffmann-La Roche Ag |
DIHYDROQUINOLINONES
|
CN111315735B
(zh)
|
2017-09-04 |
2024-03-08 |
C4医药公司 |
二氢苯并咪唑酮
|
EP3679026A1
(en)
|
2017-09-04 |
2020-07-15 |
C4 Therapeutics, Inc. |
Glutarimide
|
AU2018338314A1
(en)
|
2017-09-22 |
2020-04-09 |
Kymera Therapeutics, Inc |
Protein degraders and uses thereof
|
WO2019060693A1
(en)
*
|
2017-09-22 |
2019-03-28 |
Kymera Therapeutics, Inc. |
CRBN LIGANDS AND USES THEREOF
|
EP3710002A4
(en)
|
2017-11-16 |
2021-07-07 |
C4 Therapeutics, Inc. |
DEGRADER AND DEGRONE FOR TARGETED PROTEIN DEGRADATION
|
US11065231B2
(en)
|
2017-11-17 |
2021-07-20 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
|
WO2019133531A1
(en)
|
2017-12-26 |
2019-07-04 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
US11512080B2
(en)
|
2018-01-12 |
2022-11-29 |
Kymera Therapeutics, Inc. |
CRBN ligands and uses thereof
|
EP3737666A4
(en)
|
2018-01-12 |
2022-01-05 |
Kymera Therapeutics, Inc. |
PROTEIN DEGRADANTS AND USES THEREOF
|
WO2019148055A1
(en)
|
2018-01-26 |
2019-08-01 |
Yale University |
Imide-based modulators of proteolysis and methods of use
|
US11028088B2
(en)
|
2018-03-10 |
2021-06-08 |
Yale University |
Modulators of BTK proteolysis and methods of use
|
JP2021519337A
(ja)
|
2018-03-26 |
2021-08-10 |
シー4 セラピューティクス, インコーポレイテッド |
Ikarosの分解のためのセレブロン結合剤
|
CN112166114A
(zh)
|
2018-04-01 |
2021-01-01 |
阿尔维纳斯运营股份有限公司 |
Brm靶向化合物和相关使用方法
|
US11161841B2
(en)
|
2018-04-04 |
2021-11-02 |
Arvinas Operations, Inc. |
Modulators of proteolysis and associated methods of use
|
CN112312904A
(zh)
|
2018-04-16 |
2021-02-02 |
C4医药公司 |
螺环化合物
|
JP7458324B2
(ja)
|
2018-04-23 |
2024-03-29 |
セルジーン コーポレイション |
置換された4-アミノイソインドリン-1,3-ジオン化合物、及びリンパ腫の治療のためのそれらの使用
|
EP3578561A1
(en)
|
2018-06-04 |
2019-12-11 |
F. Hoffmann-La Roche AG |
Spiro compounds
|
JP7328263B2
(ja)
*
|
2018-06-29 |
2023-08-16 |
ダナ-ファーバー キャンサー インスティテュート,インコーポレイテッド |
免疫調節化合物
|
CA3102217A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Dana-Farber Cancer Institute, Inc. |
Bispecific degraders
|
EP3817748A4
(en)
|
2018-07-06 |
2022-08-24 |
Kymera Therapeutics, Inc. |
TRICYCLIC CRBN LIGANDS AND USES THEREOF
|
AR116109A1
(es)
|
2018-07-10 |
2021-03-31 |
Novartis Ag |
Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos
|
US11192877B2
(en)
|
2018-07-10 |
2021-12-07 |
Novartis Ag |
3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
|
WO2020023851A1
(en)
|
2018-07-26 |
2020-01-30 |
Yale University |
Bifunctional substitued pyrimidines as modulators of fak proteolyse
|
US11639354B2
(en)
|
2018-07-31 |
2023-05-02 |
Fimecs, Inc. |
Heterocyclic compound
|
CN108774215A
(zh)
*
|
2018-08-15 |
2018-11-09 |
翟学旭 |
含氮杂环类衍生物及其在视网膜新生血管疾病中的应用
|
EP3841100A1
(en)
|
2018-08-20 |
2021-06-30 |
Arvinas Operations, Inc. |
Proteolysis targeting chimeric (protac) compound with e3 ubiquitin ligase binding activity and targeting alpha-synuclein protein for treating neurodegenerative diseases
|
US11969472B2
(en)
|
2018-08-22 |
2024-04-30 |
Cullgen (Shanghai), Inc. |
Tropomyosin receptor kinase (TRK) degradation compounds and methods of use
|
EP3846800A4
(en)
|
2018-09-04 |
2022-08-24 |
C4 Therapeutics, Inc. |
COMPOUNDS FOR THE DEGRADATION OF BRD9 OR MTH1
|
CN112654619B
(zh)
*
|
2018-09-07 |
2022-08-30 |
南京明德新药研发有限公司 |
三环并呋喃取代哌啶二酮类化合物
|
AU2019389174A1
(en)
|
2018-11-30 |
2021-07-01 |
Kymera Therapeutics, Inc. |
Irak degraders and uses thereof
|
AU2019391016A1
(en)
*
|
2018-12-03 |
2021-05-13 |
Dana-Farber Cancer Institute, Inc. |
Small molecule degraders of helios and methods of use
|
TW202039434A
(zh)
|
2018-12-19 |
2020-11-01 |
美商西建公司 |
經取代之3-((3-胺基苯基)胺基)哌啶-2,6-二酮化合物、其組合物及使用彼等之治療方法
|
KR20210118816A
(ko)
|
2018-12-19 |
2021-10-01 |
셀진 코포레이션 |
치환된 3-((3-아미노페닐)아미노)피페리딘-2,6-디온 화합물, 이의 조성물, 및 이를 사용한 치료 방법
|
EP3897631A4
(en)
*
|
2018-12-20 |
2022-11-23 |
C4 Therapeutics, Inc. |
TARGETED PROTEIN DEGRADATION
|
WO2020162725A1
(ko)
*
|
2019-02-07 |
2020-08-13 |
한국화학연구원 |
표적 단백질 eed 분해 유도 데그라듀서, 이의 제조방법 및 이를 유효성분으로 함유하는 eed, ezh2, 또는 prc2 관련 질환의 예방 또는 치료용 약학적 조성물
|
WO2020172655A1
(en)
*
|
2019-02-23 |
2020-08-27 |
New York University |
Photoswitchable protacs and synthesis and uses thereof
|
WO2020206424A1
(en)
|
2019-04-05 |
2020-10-08 |
Kymera Therapeutics, Inc. |
Stat degraders and uses thereof
|
WO2020214555A1
(en)
|
2019-04-16 |
2020-10-22 |
Northwestern University |
Bifunctional compounds comprising apcin-a and their use in the treatment of cancer
|
EP3957633A4
(en)
*
|
2019-04-18 |
2022-12-28 |
Hinova Pharmaceuticals Inc. |
CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTORS AND THEIR USE
|
US20230087825A1
(en)
*
|
2019-06-10 |
2023-03-23 |
Kymera Therapeutics, Inc. |
Smarca degraders and uses thereof
|
WO2020252397A1
(en)
*
|
2019-06-12 |
2020-12-17 |
Baylor College Of Medicine |
Small molecule proteolysis-targeting chimeras and methods of use thereof
|
CR20210687A
(es)
|
2019-06-25 |
2022-03-03 |
Gilead Sciences Inc |
PROTEÍNAS DE FUSIÓN FLT3L-Fc Y MÉTODOS DE USO
|
JP2022540935A
(ja)
*
|
2019-07-17 |
2022-09-20 |
アルビナス・オペレーションズ・インコーポレイテッド |
タウタンパク質標的化化合物および関連する使用方法
|
US20210060008A1
(en)
*
|
2019-08-26 |
2021-03-04 |
Arvinas Operations, Inc. |
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
|
CA3151824A1
(en)
*
|
2019-08-27 |
2021-03-04 |
The Regents Of The University Of Michigan |
Cereblon e3 ligase inhibitors
|
US11905276B2
(en)
*
|
2019-09-12 |
2024-02-20 |
Medshine Discovery Inc. |
Bicyclic compound that acts as CRBN protein regulator
|
WO2021053555A1
(en)
*
|
2019-09-16 |
2021-03-25 |
Novartis Ag |
Glue degraders and methods of use thereof
|
CR20220105A
(es)
*
|
2019-09-16 |
2022-06-13 |
Novartis Ag |
Degradadores bifuncionales de brd9 y sus métodos de uso
|
CN114787159A
(zh)
|
2019-10-01 |
2022-07-22 |
阿尔维纳斯运营股份有限公司 |
Brm靶向化合物及相关使用方法
|
JP2022552006A
(ja)
|
2019-10-17 |
2022-12-14 |
アルヴィナス・オペレーションズ・インコーポレイテッド |
Bcl6標的化部分に連結されたe3ユビキチンリガーゼ結合部分を含有する二官能性分子
|
US11952349B2
(en)
|
2019-11-13 |
2024-04-09 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
CN110885332B
(zh)
*
|
2019-12-06 |
2022-03-18 |
中国人民解放军第二军医大学 |
一种PDEδ蛋白降解靶向嵌合体及其制备方法和应用
|
CA3161878A1
(en)
|
2019-12-17 |
2021-06-24 |
Matthew M. Weiss |
Irak degraders and uses thereof
|
JP2023507172A
(ja)
*
|
2019-12-17 |
2023-02-21 |
オリオニス バイオサイエンシズ,インコーポレイテッド |
タンパク質分解の調節
|
US11591332B2
(en)
|
2019-12-17 |
2023-02-28 |
Kymera Therapeutics, Inc. |
IRAK degraders and uses thereof
|
MX2022007678A
(es)
|
2019-12-19 |
2022-09-19 |
Arvinas Operations Inc |
Compuestos y metodos para la degradacion dirigida del receptor de androgenos.
|
JP2023509375A
(ja)
|
2019-12-20 |
2023-03-08 |
シーフォー セラピューティクス, インコーポレイテッド |
Egfrの分解のためのイソインドリノン及びインダゾール化合物
|
AU2020412780A1
(en)
|
2019-12-23 |
2022-07-21 |
Kymera Therapeutics, Inc. |
SMARCA degraders and uses thereof
|
WO2021146386A1
(en)
*
|
2020-01-14 |
2021-07-22 |
The Trustees Of Columbia University In The City Of New York |
Compositions and methods for targeted protein stabilization by redirecting endogenous deubiquitinases
|
TW202140448A
(zh)
*
|
2020-01-16 |
2021-11-01 |
大陸商江蘇恆瑞醫藥股份有限公司 |
並環醯亞胺類衍生物、其製備方法及其在醫藥上的應用
|
WO2021143816A1
(zh)
*
|
2020-01-16 |
2021-07-22 |
江苏恒瑞医药股份有限公司 |
稠合酰亚胺类衍生物、其制备方法及其在医药上的应用
|
EP4103285A2
(en)
|
2020-02-14 |
2022-12-21 |
Jounce Therapeutics, Inc. |
Antibodies and fusion proteins that bind to ccr8 and uses thereof
|
EP3875456A1
(en)
*
|
2020-03-02 |
2021-09-08 |
Technische Universität Darmstadt |
Hetero-bifunctional proteolysis-targeting chimeras (protacs) for the selective degradation of fk506-binding proteins (fkbps)
|
MX2022010952A
(es)
|
2020-03-05 |
2022-10-07 |
C4 Therapeutics Inc |
Compuestos para la degradacion dirigida de brd9.
|
CN111249276B
(zh)
*
|
2020-03-05 |
2021-07-13 |
南京巴傲得生物科技有限公司 |
吲哚布洛芬制备cbp溴区抑制试剂的用途
|
AU2021229979A1
(en)
*
|
2020-03-06 |
2022-10-27 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
Crystal of tricyclic compound acting on CRBN protein and preparation method therefor
|
CN113387931A
(zh)
*
|
2020-03-13 |
2021-09-14 |
四川海思科制药有限公司 |
一种具有抑制或降解蛋白激酶的化合物及其制备方法和药学上的应用
|
JP2023517393A
(ja)
*
|
2020-03-17 |
2023-04-25 |
メッドシャイン ディスカバリー インコーポレイテッド |
タンパク質分解調整剤およびその使用方法
|
JP2023518202A
(ja)
*
|
2020-03-18 |
2023-04-28 |
ダナ-ファーバー キャンサー インスティテュート,インコーポレイテッド |
Petトレーサーpbb3に基づく異常タウの標的化ディグレーダー
|
CA3171258A1
(en)
|
2020-03-19 |
2021-09-23 |
Nan JI |
Mdm2 degraders and uses thereof
|
US20230158158A1
(en)
*
|
2020-03-27 |
2023-05-25 |
Uppthera |
Pyrazolo quinazoline derivative compounds inducing selective degradation of plk1
|
WO2021210878A1
(ko)
*
|
2020-04-17 |
2021-10-21 |
광주과학기술원 |
Crbn 결합 펩티드 및 이를 이용한 알츠하이머 병 예방 또는 치료용 조성물
|
WO2021219077A1
(zh)
*
|
2020-04-29 |
2021-11-04 |
泰比棣医药科技(石家庄)有限公司 |
一种组织靶向的蛋白靶向降解化合物及其用途
|
CN113582974B
(zh)
*
|
2020-04-30 |
2022-05-17 |
江西济民可信集团有限公司 |
一类作为蛋白降解剂的化合物及其制备方法和医药用途
|
WO2021231927A1
(en)
*
|
2020-05-14 |
2021-11-18 |
The Regents Of The University Of Michigan |
Androgen receptor protein degraders with a tricyclic cereblon ligand
|
WO2021236885A1
(en)
*
|
2020-05-21 |
2021-11-25 |
Dana-Farber Cancer Institute, Inc. |
Piperidine-2,6-diones as small molecule degraders of helios and methods of use
|
TW202210483A
(zh)
|
2020-06-03 |
2022-03-16 |
美商凱麥拉醫療公司 |
Irak降解劑之結晶型
|
IL298962A
(en)
*
|
2020-06-12 |
2023-02-01 |
Shanghai Jemincare Pharmaceuticals Co Ltd |
Phthalazinone compound, its preparation method and its medical use
|
KR102559329B1
(ko)
*
|
2020-07-02 |
2023-07-25 |
포항공과대학교 산학협력단 |
신규한 프로탁 키메라 화합물, 이를 포함하는 표적 단백질 분해를 통한 질환의 예방, 개선 또는 치료용 약학적 조성물
|
US20230357193A1
(en)
*
|
2020-07-09 |
2023-11-09 |
Sichuan Haisco Pharmaceutical Co., Ltd. |
Compound capable of inhibiting and degrading androgen receptors, and pharmaceutical compositions and pharmaceutical uses thereof
|
KR102646850B1
(ko)
*
|
2020-07-21 |
2024-03-13 |
주식회사 유빅스테라퓨틱스 |
안드로겐 수용체 분해용 화합물 및 이들의 의약 용도
|
KR20220014952A
(ko)
*
|
2020-07-29 |
2022-02-08 |
한국화학연구원 |
안드로겐 수용체의 저해 또는 분해용 화합물 및 이들의 의약 용도
|
AU2021319847A1
(en)
*
|
2020-08-03 |
2023-03-02 |
Captor Therapeutics S.A. |
Low molecular weight protein degraders and their applications
|
EP4194457A1
(en)
*
|
2020-08-05 |
2023-06-14 |
Shanghai Leadingtac Pharmaceutical Co., Ltd. |
Compound for targeting and degrading protein, and preparation method therefor and use thereof
|
WO2022048605A1
(zh)
*
|
2020-09-04 |
2022-03-10 |
南昌奥瑞药业有限公司 |
一种杂环化合物、其制备方法、中间体、组合物以及应用
|
CN114163444B
(zh)
*
|
2020-09-11 |
2023-07-14 |
江苏恒瑞医药股份有限公司 |
一种用于雄激素受体蛋白靶向降解的嵌合体化合物、其制备方法及其在医药上的应用
|
CN114181277A
(zh)
*
|
2020-09-15 |
2022-03-15 |
江苏恒瑞医药股份有限公司 |
一种用于雄激素受体蛋白靶向降解的嵌合体化合物、其制备方法及其在医药上的应用
|
AU2021353968A1
(en)
|
2020-09-30 |
2023-06-08 |
Astrazeneca Ab |
Compounds and their use in treating cancer
|
EP4277901A1
(en)
|
2021-01-13 |
2023-11-22 |
Monte Rosa Therapeutics, Inc. |
Isoindolinone compounds
|
WO2022166879A1
(zh)
*
|
2021-02-04 |
2022-08-11 |
正大天晴药业集团股份有限公司 |
苯并七元环类双功能化合物及其应用
|
EP4294790A1
(en)
*
|
2021-02-19 |
2023-12-27 |
Kymera Therapeutics, Inc. |
Smarca degraders and uses thereof
|
EP4308559A1
(en)
*
|
2021-03-15 |
2024-01-24 |
Novartis AG |
Benzisoxazole derivatives and uses thereof
|
US11834458B2
(en)
|
2021-03-23 |
2023-12-05 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
BR112023019967A2
(pt)
|
2021-03-29 |
2023-11-14 |
Jiangsu Hengrui Pharmaceuticals Co Ltd |
Composto de tetra-hidronaftaleno e método de preparação para o mesmo e uso do mesmo em medicina
|
CN115141179A
(zh)
*
|
2021-03-31 |
2022-10-04 |
江苏恒瑞医药股份有限公司 |
一种新型苯并杂环基类衍生物、其制备方法及其在医药上的应用
|
JP2024515619A
(ja)
|
2021-04-16 |
2024-04-10 |
アルビナス・オペレーションズ・インコーポレイテッド |
Bcl6タンパク質分解の調節因子および関連する使用方法
|
CN113603676B
(zh)
*
|
2021-04-28 |
2022-05-24 |
浙江工业大学 |
基于厄洛替尼靶向降解egfr蛋白小分子化合物及其制备方法和应用
|
AU2022269568A1
(en)
*
|
2021-05-03 |
2023-11-16 |
Nuvation Bio Inc. |
Anti-cancer nuclear hormone receptor-targeting compounds
|
IL308219A
(en)
|
2021-05-05 |
2024-01-01 |
Biogen Ma Inc |
Compounds to Target Broton Tyrosine Kinase Degradation
|
US20220389394A1
(en)
|
2021-05-18 |
2022-12-08 |
Gilead Sciences, Inc. |
METHODS OF USING FLT3L-Fc FUSION PROTEINS
|
WO2022250350A1
(ko)
*
|
2021-05-26 |
2022-12-01 |
주식회사 이노큐어테라퓨틱스 |
피페리딘디온 유도체
|
KR102474999B1
(ko)
*
|
2021-05-26 |
2022-12-07 |
주식회사 이노큐어테라퓨틱스 |
피페리딘디온 유도체
|
KR102489160B1
(ko)
*
|
2021-05-26 |
2023-01-18 |
주식회사 이노큐어테라퓨틱스 |
피페리딘디온 유도체
|
EP4116298A4
(en)
*
|
2021-05-26 |
2023-06-28 |
Innocure Therapeutics, Inc. |
Piperidinedione derivative
|
WO2022255890A1
(en)
*
|
2021-06-01 |
2022-12-08 |
Captor Therapeutics S.A. |
Compounds which bind to cereblon, and use thereof
|
WO2022255888A1
(en)
*
|
2021-06-01 |
2022-12-08 |
Captor Therapeutics S.A. |
Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target mcl-1 protein
|
WO2022255889A1
(en)
*
|
2021-06-01 |
2022-12-08 |
Captor Therapeutics S.A. |
Compounds which bind to cereblon, and use thereof
|
WO2023283130A1
(en)
|
2021-07-04 |
2023-01-12 |
Newave Pharmaceutical Inc. |
Isoquinoline derivatives as mutant egfr modulators and uses thereof
|
EP4366834A1
(en)
|
2021-07-07 |
2024-05-15 |
Biogen MA Inc. |
Compounds for targeting degradation of irak4 proteins
|
KR20240035526A
(ko)
|
2021-07-07 |
2024-03-15 |
바이오젠 엠에이 인코포레이티드 |
Irak4 단백질의 분해를 표적하는 화합물
|
TW202317546A
(zh)
|
2021-07-09 |
2023-05-01 |
美商普萊克斯姆公司 |
調節ikzf2之芳基化合物及醫藥組合物
|
TW202321219A
(zh)
*
|
2021-08-11 |
2023-06-01 |
大陸商四川海思科製藥有限公司 |
雜環衍生物及其組合物和藥學上的應用
|
KR20240048010A
(ko)
|
2021-08-18 |
2024-04-12 |
누릭스 테라퓨틱스 인코포레이티드 |
인터루킨-1 수용체 관련 키나제의 이작용성 분해제 및 이의 치료 용도
|
TW202315606A
(zh)
*
|
2021-08-23 |
2023-04-16 |
大陸商上海領泰生物醫藥科技有限公司 |
Irak4降解劑及其製備方法和應用
|
WO2023034411A1
(en)
|
2021-09-01 |
2023-03-09 |
Oerth Bio Llc |
Compositions and methods for targeted degradation of proteins in a plant cell
|
WO2023056443A1
(en)
*
|
2021-10-01 |
2023-04-06 |
Dana-Farber Cancer Institute, Inc. |
Binders of cereblon and methods of use thereof
|
TW202322799A
(zh)
*
|
2021-10-06 |
2023-06-16 |
美商C4醫藥公司 |
冠狀病毒非結構性蛋白3降解化合物
|
CA3235512A1
(en)
*
|
2021-10-22 |
2023-04-27 |
Xiaobao Yang |
Crbn e3 ligase ligand compound, protein degrader developed based thereon and their applications
|
CA3234909A1
(en)
|
2021-10-28 |
2023-05-04 |
Gilead Sciences, Inc. |
Pyridizin-3(2h)-one derivatives
|
WO2023077030A1
(en)
|
2021-10-29 |
2023-05-04 |
Gilead Sciences, Inc. |
Cd73 compounds
|
WO2023081224A1
(en)
*
|
2021-11-03 |
2023-05-11 |
St. Jude Children's Research Hospital, Inc. |
Substituted n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4- yl)methyl)benzamide analogs as modulators of cereblon protein
|
WO2023081452A1
(en)
*
|
2021-11-05 |
2023-05-11 |
University Of South Carolina |
Small-molecule degraders of cdk8 and cdk19
|
WO2023097031A1
(en)
|
2021-11-24 |
2023-06-01 |
Arvinas Operations, Inc. |
Brm targeting compounds and associated methods of use
|
WO2023096987A1
(en)
|
2021-11-24 |
2023-06-01 |
Arvinas Operations, Inc. |
Brm targeting compounds and associated methods of use
|
WO2023122581A2
(en)
|
2021-12-22 |
2023-06-29 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
CA3237577A1
(en)
|
2021-12-22 |
2023-06-29 |
Gilead Sciences, Inc. |
Ikaros zinc finger family degraders and uses thereof
|
CN114085213B
(zh)
*
|
2022-01-20 |
2022-03-25 |
苏州国匡医药科技有限公司 |
一种arv-471的制备方法
|
TW202340168A
(zh)
|
2022-01-28 |
2023-10-16 |
美商基利科學股份有限公司 |
Parp7抑制劑
|
TW202346277A
(zh)
|
2022-03-17 |
2023-12-01 |
美商基利科學股份有限公司 |
Ikaros鋅指家族降解劑及其用途
|
WO2023180388A1
(en)
*
|
2022-03-24 |
2023-09-28 |
Glaxosmithkline Intellectual Property Development Limited |
2,4-dioxotetrahydropyrimidinyl derivatives as degrons in protacs
|
US11618751B1
(en)
|
2022-03-25 |
2023-04-04 |
Ventus Therapeutics U.S., Inc. |
Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
|
WO2023205701A1
(en)
|
2022-04-20 |
2023-10-26 |
Kumquat Biosciences Inc. |
Macrocyclic heterocycles and uses thereof
|
WO2023205719A1
(en)
|
2022-04-21 |
2023-10-26 |
Gilead Sciences, Inc. |
Kras g12d modulating compounds
|
WO2023212599A2
(en)
*
|
2022-04-26 |
2023-11-02 |
Endotarget Inc. |
Compounds and methods for targeted degradation of estrogen receptors
|
WO2024002289A1
(en)
*
|
2022-06-30 |
2024-01-04 |
Anhorn Medicines Co., Ltd. |
Protein degradation compounds and methods of use
|
US20240116928A1
(en)
|
2022-07-01 |
2024-04-11 |
Gilead Sciences, Inc. |
Cd73 compounds
|
WO2024015412A1
(en)
*
|
2022-07-12 |
2024-01-18 |
Regents Of The University Of Michigan |
Tetrahydronaphthalene derivatives as estrogen receptor degraders
|
CN115089588A
(zh)
*
|
2022-08-22 |
2022-09-23 |
云南大学 |
达沙布韦作为e3连接酶新型配体构建protac的应用
|
WO2024050016A1
(en)
|
2022-08-31 |
2024-03-07 |
Oerth Bio Llc |
Compositions and methods for targeted inhibition and degradation of proteins in an insect cell
|
WO2024054591A1
(en)
|
2022-09-07 |
2024-03-14 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|
WO2024054953A1
(en)
*
|
2022-09-08 |
2024-03-14 |
Halda Therapeutics Opco, Inc. |
Heterobifunctional compounds and methods of treating disease
|
WO2024054954A1
(en)
*
|
2022-09-08 |
2024-03-14 |
Halda Therapeutics Opco, Inc. |
Heterobifunctional compounds and methods of treating disease
|
WO2024054955A1
(en)
*
|
2022-09-08 |
2024-03-14 |
Halda Therapeutics Opco, Inc. |
Heterobifunctional compounds and methods of treating disease
|
WO2024051766A1
(zh)
*
|
2022-09-08 |
2024-03-14 |
标新生物医药科技(上海)有限公司 |
基于cereblon蛋白设计的分子胶化合物及其应用
|
US20240158370A1
(en)
|
2022-09-09 |
2024-05-16 |
Innovo Therapeutics, Inc. |
CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS
|
WO2024056005A1
(zh)
*
|
2022-09-14 |
2024-03-21 |
先声再明医药有限公司 |
多并环类化合物及其用途
|
WO2024064316A1
(en)
|
2022-09-23 |
2024-03-28 |
Regents Of The University Of Michigan |
Compounds and compositions as smarca2/4 inhibitors and uses thereof
|
WO2024073475A1
(en)
*
|
2022-09-27 |
2024-04-04 |
Oncopia Therapeutics, Inc. D/B/A Proteovant Therapeutics, Inc. |
Cereblon ligands and uses thereof
|
WO2024067781A1
(zh)
*
|
2022-09-29 |
2024-04-04 |
江苏恒瑞医药股份有限公司 |
一种四氢萘类衍生物的可药用盐、晶型及制备方法
|
WO2024067793A1
(zh)
*
|
2022-09-29 |
2024-04-04 |
海南先声再明医药股份有限公司 |
一类稠环化合物及其用途
|
CN117801051A
(zh)
*
|
2022-09-30 |
2024-04-02 |
苏州德亘生物医药有限公司 |
一类eRF3a靶向蛋白降解机制治疗人类肿瘤的药物
|
WO2024091975A1
(en)
|
2022-10-24 |
2024-05-02 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|